The Site Quality Head is responsible for leading the Quality Assurance and Quality Control divisions at the site and for ensuring site compliance with applicable regulations and meet business needs. This position’s responsibilities include but are not limited to overseeing of the site quality, establishing and maintaining a risk-based and science-based quality system, ensuring implementationRead more
Blog
A look at the prospectus for the merger tells an instructive tale of how Kite CEO Arie Belldegrun turned a single bid into a huge payday by capitalizing not only on his company’s valuable innovation in the red-hot field of immuno-oncology, but also on Gilead’s desperate need to make a game-changing deal.
Patients with a specific type of acute myeloid leukemia have their first treatment option with the FDA’s accelerated approval Tuesday of Idhifa from partners Celgene and Axios.
Every year, at least 700,000 people die worldwide from infections that no longer respond to antibiotics. That toll could balloon to 10 million by 2050. READ FULL ARTICLERead more
More than two years ago, one analyst touted Vertex’s as Gilead’s best option for a buyout that could chip in top-line growth once times got hard in hepatitis C.
Orphan drug sales have nearly doubled since 2008 and sales for the super-pricey drug class will nearly double—again—by 2022 to $209 billion, according to a new industry analysis.
Highly Competitive Base + 30% Target + LTI + Relocation Assistance
Seattle Genetics has called a halt to all clinical testing of vadastuximab talirine (SGN-CD33A) after seeing a higher rate of patient deaths with the drug in a phase 3 trial.
Amazon said on Friday that it had agreed to buy the upscale supermarket chain Whole Foods for $13.4 billion, in the online retailer’s latest push into the grocery business.
The European Commission made clear this week how it intends to treat API makers from the U.K.
